Clover Health Investments... (CLOV)
Bid | 3.32 |
Market Cap | 1.71B |
Revenue (ttm) | 1.37B |
Net Income (ttm) | -43.01M |
EPS (ttm) | -0.09 |
PE Ratio (ttm) | -37.28 |
Forward PE | -33.45 |
Analyst | Buy |
Ask | 3.39 |
Volume | 3,134,591 |
Avg. Volume (20D) | 5,591,150 |
Open | 3.35 |
Previous Close | 3.35 |
Day's Range | 3.27 - 3.36 |
52-Week Range | 0.70 - 4.87 |
Beta | 2.00 |
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee....
Analyst Forecast
According to 3 analyst ratings, the average rating for CLOV stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 34.13% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

2 months ago · seekingalpha.com
Clover Health: Expected Margin Contraction Is A Prelude To Exponential GrowthClover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and r...

2 months ago · seekingalpha.com
Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call TranscriptClover Health Investments, Corp. (NASDAQ:CLOV ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Office...

2 months ago · seekingalpha.com
Clover Health: Watch Out For Volatility Following Q4 Earnings ResultsI remain bullish on Clover Health long-term but prefer to Hold until Q4 2024 earnings for higher conviction before initiating a long position in this stock. I believe the 40% YTD rise and 60% retail o...